Cargando…
Advantage of using a recombinant activated factor VII in traumatic haemorrhagic shock: The Bordeaux experience
INTRODUCTION: Several series of patient studies have been published on the use of rFVIIa in traumatic haemorrhagic shock, although to date no international recommendations have been produced. France does not currently recognise traumatic haemorrhagic shock as an appropriate indication for the use of...
Autores principales: | Morel, Nicolas, Chabarttier, Cyrille, Merson, Laurent, Lelias, Agathe, Bernard, Jean-Christophe, Delaunay, François, Dabadie, Philippe, Janvier, Gérard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391838/ https://www.ncbi.nlm.nih.gov/pubmed/22787344 http://dx.doi.org/10.4103/0974-2700.96483 |
Ejemplares similares
-
Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven(®)) in obstetrical haemorrhagic shock
por: Sobieszczyk, S, et al.
Publicado: (2003) -
Recombinant activated factor VII in post partum haemorrhage
por: Magon, Navneet, et al.
Publicado: (2013) -
Bristol and Bordeaux
por: Cosh, J. A.
Publicado: (1957) -
The Bordeaux Conference
Publicado: (1924) -
La Tauromaquia and the bulls of Bordeaux /
por: Goya y Lucientes, Francisco, 1746-1828
Publicado: (1969)